Identifying stage III colorectal cancer patients: The influence of the patient, surgeon, and pathologist

被引:104
作者
Morris, Eva Judith Ann
Maughan, Nicola Joanne
Forman, David
Quirke, Philip
机构
[1] Cookridge Hosp, No & Yorkshire Canc Registry & Informat Serv, Leeds LS16 6QB, W Yorkshire, England
[2] Univ Leeds, Canc Epidemiol Grp, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England
[3] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England
[4] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
关键词
D O I
10.1200/JCO.2007.11.0445
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Nodal yields from resected colorectal cancers vary greatly. This study sought to determine what patient, tumor, and management factors influence the number of nodes retrieved and to determine if the extent of lymphadenectomy affects stage allocation and influences survival. Patients and Methods Retrospective study of the nodal yields of 7,062 surgically resected colorectal cancer patients for whom colorectal pathology minimum data sets had been collected. The percentage of patients diagnosed as stage III was compared across nodal yield categories. A threshold for an adequate lymphadenectomy was defined as retrieval of 12 nodes. Binary logistic regression was used to determine factors associated with obtaining an adequate lymphadenectomy. Results Median nodal yields increased over the study period from 7 (interquartile range [IQR], 4 to 11) in 1995 to 13 (IQR 8 to 19) in 2003. There was no difference in yield by cancer site or sex, but yields were lower in older patients. Yields increased with increasing local invasion and stage of tumor. The percentage of patients diagnosed as stage III increased as yields increased. Five-year survival was lower in those patients who did not have an adequate lymphadenectomy. Adequate lymphadenectomy was significantly more likely in patients with advanced tumors and when the surgery and pathology was undertaken by a specialist. Older patients were significantly less likely to receive an adequate lymphadenectomy. Conclusion Variations in nodal yield are due to idiosyncratic patient and tumor characteristics and differences in the quality of surgery and pathology undertaken. Adequate lymphadenectomy is essential to ensure correct stage allocation and optimal survival.
引用
收藏
页码:2573 / 2579
页数:7
相关论文
共 44 条
[1]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[2]  
Baxandall M, 2006, J PATHOL, V208, p29A
[3]   Lymph node evaluation in colorectal cancer patients: A population-based study [J].
Baxter, NN ;
Virnig, DJ ;
Rothenberger, DA ;
Morris, AM ;
Jessurun, J ;
Virnig, BA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (03) :219-225
[4]   Colorectal cancer pathology reporting: A regional audit [J].
Bull, AD ;
Biffin, AHB ;
Mella, J ;
Radcliffe, AG ;
Stamatakis, JD ;
Steele, RJC ;
Williams, GT .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (02) :138-142
[5]  
Caplin S, 1998, CANCER, V83, P666, DOI 10.1002/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.3.CO
[6]  
2-S
[7]   Lymph node recovery from colorectal tumor specimens: Recommendation for a minimum number of lymph nodes to be examined [J].
Cianchi, F ;
Palomba, A ;
Boddi, V ;
Messerini, L ;
Pucciani, F ;
Perigli, G ;
Bechi, P ;
Cortesini, C .
WORLD JOURNAL OF SURGERY, 2002, 26 (03) :384-389
[8]   Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? [J].
Cserni, G ;
Vinh-Hung, V ;
Burzykowski, T .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 81 (02) :63-69
[9]   Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years - Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities [J].
Goldstein, NS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (02) :179-189
[10]  
Görög N, 2003, PATHOL ONCOL RES, V9, P180, DOI 10.1007/BF03033734